|
|
|
|
|
13.06.25 - 20:09
|
XFRA: Deletion of Instruments from Boerse Frankfurt - 13.06.2025 (XETRA)
|
|
|
The following instruments on Boerse Frankfurt do have their last trading day on 13.06.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.06.2025
ISIN Name
CA46125M1041 INVERITE INSIGHTS INC.
CH1391448177 BEONE MEDICINES AG
GB00BBPV5329 SCIENCE IN SPORT LS-,10
IT0001498481 FIDIA EO 1
IT0005337123 ASKOLL EVA S.P.A.
US38000Q1022 GLYCOMIMETICS INC. DL-001
US4661101034 JBS S.A. ADR/2O.N....
|
|
|
13.06.25 - 16:57
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
IT0001498481 Fidia S.p.A. 13.06.2025 IT0005654683 Fidia S.p.A. 16.06.2025 Tausch 100:1
CA46125M1041 Inverite Insights Inc. 13.06.2025 CA46125M2031 Inverite Insights Inc. 16.06.2025 Tausch 6:1
US38000Q1022 GlycoMimetics Inc. 13.06.2025 US38000Q2012 GlycoMimetics Inc. 16.06.2025 Tausch 100:1...
|
|
|
05.06.25 - 22:06
|
GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals (Business Wire)
|
|
|
—GlycoMimetics Board of Directors approves 1-for-100 reverse stock split—ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) (“GlycoMimetics”) today announced that its stockholders have approved the proposed merger (the “Merger”) with Crescent Biopharma, Inc. (“Crescent”), along with all proposals related to the Merger. The proposals were voted upon at GlycoMimetics' special meeting in lieu of the annual meeting of stockholders held on June 5, 2025 (the “Special Meeting”), including a reverse stock split of GlycoMimetics' common stock to be effected at the discretion of the board of directors of GlycoMimetics (the “Board”) within the parameters approved by GlycoMimetics' stockholders.
On June 5, 2025, following the Special Meeting, the Board approved a reverse stock split of GlycoMimetics' common stock at a ratio of 1-for-100. Following the anticipated closing of the Merger, the combined company's common stock is expected to begin trading on a post-reverse stoc...
|
|
|
|
|
01.11.24 - 09:00
|
GlycoMimetics: +191% nach Übernahme-Ankündigung (Sharedeals)
|
|
|
Die GlycoMimetics-Aktie (WKN: A1412H) erlebte am Dienstag eine wahre Kursexplosion. Nach Bekanntgabe einer geplanten Übernahme schoss der Kurs um sagenhafte +191% in die Höhe. Aber was genau steckt hinter diesem Börsenfeuerwerk? Fusion mit Crescent Biopharma löst Kursrallye aus Die Nachricht von der geplanten Übernahme durch Crescent Biopharma ließ die GlycoMimetics-Aktie förmlich explodieren. Wie der US-Konzern […]
The post GlycoMimetics: +191% nach Übernahme-Ankündigung first appeared on sharedeals.de....
|
|
|
|
|
31.10.24 - 13:40
|
XFRA : GKO: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
GLYCOMIMETICS INC. DL-001 GKO US38000Q1022
AB/FROM ONWARDS 31.10.2024 13:22 CET...
|
|
|
|
|
29.10.24 - 14:01
|
Pre-market Movers: GLYC, BKYI, LIXT, SHPH, PFIE. (AFX)
|
|
|
NORWALK (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green GlycoMimetics, Inc. (GLYC) is up over 163% at $0.4433. ......
|
|
|
|
|
29.10.24 - 12:22
|
XFRA : GKO: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
GLYCOMIMETICS INC. DL-001 GKO US38000Q1022 BAW/UFN...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
